Peptide Merchant Accounts in 2026: Why Sellers Get Shut Down and How to Stay Approved

If you sell peptides online, you have probably heard some version of this story: a store launches on a mainstream payment app, sales take off, and a few weeks later the account is closed and the funds are held for months. It is one of the most common problems in high-risk payments. It is also one of the most avoidable.

This guide explains why peptide businesses are treated as high risk, what actually triggers shutdowns, and what a stable, properly underwritten merchant account looks like.

Why processors treat peptides as high risk

Processors and their sponsor banks carry the financial and reputational risk of every merchant they board. Peptides concentrate several risk factors in one category:

• Regulatory movement. The FDA's treatment of compounded peptides has changed several times since 2023, and processors watch those changes closely. When the rules around a product shift, underwriting becomes more conservative across the whole category.
• Card-network oversight. Visa and Mastercard both run programs that monitor merchants selling unapproved drugs, nutraceuticals, and related products. Acquirers that board these merchants are expected to monitor them closely.
• Marketing claims. Product pages that imply a peptide treats or cures a condition create FDA and FTC exposure, and underwriters review websites for exactly that language.
• Dispute exposure. Shipping delays, buyer confusion, and subscription offers can push chargebacks up quickly.

None of this means peptide businesses cannot get approved. It means approval has to come from a partner whose banks knowingly accept the category.

Why payment apps shut peptide sellers down

Payment aggregators like Stripe, Square, and PayPal approve accounts almost instantly, often before anyone has reviewed what you sell. Their automated systems later scan product names, descriptions, and transaction patterns. When a peptide product is detected, the account is typically closed under the platform's restricted-business rules, and settled funds may be held to cover potential refunds and chargebacks.

The lesson: a fast approval is not the same as a real approval. An account that was never underwritten for your category is always one automated review away from closure.

Chargeback thresholds just got tighter

Visa's Acquirer Monitoring Program (VAMP) combines fraud reports and disputes into a single ratio. On April 1, 2026, the "excessive" threshold for U.S. merchants dropped from 2.2% to 1.5%. Merchants over that line can face fees of about $8 per disputed or fraudulent transaction, passed through their acquirer.

Just as important, acquirers are measured against much stricter portfolio-level limits, so many set their own internal thresholds well below Visa's. For a high-risk category like peptides, keeping disputes low is not optional. It is the difference between a stable account and a termination.

What underwriters want to see from peptide merchants

The strongest applications make the underwriter's job easy. Before you apply, have these ready:

1. Certificates of analysis (COAs) from third-party labs for the products you sell.
2. A compliant website. Clear product labeling, appropriate disclaimers, and no treatment or cure claims anywhere on the site, including blog posts and customer reviews you display.
3. Complete policy pages. Refund, shipping, privacy, and terms of service pages that are easy to find.
4. Age and purchase controls where appropriate for your products.
5. Processing history. Recent merchant statements, even from a closed account, help demonstrate volume and dispute rates.
6. Business documents. Formation documents, a business bank account, and owner identification.

How to keep your peptide account stable

Approval is the start. These habits keep you processing:

• Use a clear billing descriptor so customers recognize the charge on their statement.
• Send order and shipping confirmations with tracking, and answer customer emails quickly. Many chargebacks are customers who could not reach you.
• Enroll in dispute alert programs that let you refund a disputed order before it becomes a chargeback.
• Offer ACH alongside cards. A second payment rail keeps revenue flowing if your card account is ever under review.
• Tell your processor before big changes, like a new product line, a major promotion, or a sharp jump in volume.

The bottom line

Peptide businesses get shut down when they are processing in the wrong place, not because the category is impossible. The path to stability is a merchant account underwritten by a partner whose banks accept peptides, backed by a compliant website and good dispute habits.

If you have been declined, shut down, or are worried your current account will not last, a free statement review is a good first step. A specialist can look at your current setup, your pricing, and your risk profile, and show you your options.

This article is for general information only and is not legal, tax, or financial advice. Card-brand rules and regulations change; confirm requirements with your processor or advisor.